Introduction
Hepatitis B often causes chronic infection and cirrhosis in infected infants, children, and adults. 1 Hepatitis B has become a serious burden on the healthcare systems in many countries because some patients infected with chronic hepatitis B develop cirrhosis of the liver or liver cancer. 2 In China, hepatitis B is the most widely prevalent infectious disease. 3 Henan Province is located in the middle of China and is the most populous province among the 31 mainland China provinces and municipalities. Henan has a population of nearly 97 million people. This province also has the most patients with hepatitis B virus (HBV) infection; according to a national survey conducted in 1992, 4 there were nearly 8.5 million hepatitis B surface antigen (HBsAg)-positive people in Henan Province, accounting for about 7% of the total number of HBsAg-positive patients in China.
In 1992 the Chinese government initiated a program in which all newborn babies routinely received a hepatitis B vaccine in three doses (at birth and at 1 and 6 months of age); however, all costs associated with the vaccination were paid for by the infants' families. In 2002, the hepatitis B vaccine was fully integrated into the routine infant immunization program for newborns and the vaccine costs were covered by public health funding (although some vaccination costs were still paid by the infants' families until 2005). As of 2012, this vaccination program had been in place in Henan for 20 years and the first cohort of children to receive the vaccination had reached adulthood. In order to evaluate the protective effects of vaccination, particularly in susceptible populations who were born during the past 15 years, the Henan Center for Disease Control and Prevention (HNCDC) conducted an HBV serosurvey in Henan in 2012 on a large sample of the population aged <15 years.
Methods
Planning for this study began in October 2011 and the data analysis was completed in June 2013. All of the field work was conducted between May and June 2012.
Study population
The target population comprised local residents aged 1-14 years living in 60 investigation points in 18 cities. Henan has an uneven socioeconomic distribution among the different geographic areas. Thus, a multistage stratified random cluster sampling method was used. First, 159 districts and counties in Henan Province were divided into three strata according to their level of economic development in 2011: 'high' at GDP per capita !$7000, 'middle' at GDP per capita $5000 to $6999, and 'low' at GDP per capita <$5000. Each economic layer contained 53 districts and counties, and 10 districts and counties were selected randomly from each layer for analysis. Thus, a total of 30 districts and counties were selected from the three layers, which contained 228 sub-districts and 306 townships in total. Second, based on the population ratio of the urban to rural area (4:6), 24 sub-districts and 36 townships were selected randomly from the 228 subdistricts and 306 townships. Third, all of the communities and villages of the 60 selected sub-districts and townships were numbered, and 60 communities and villages were selected randomly as the investigation points ( Figure 1 ). Persons aged 1-14 years who had been resident for more than 6 months as of the time of the survey visit were selected.
Sampling method
The design effect coefficient (D eff ) was used to assess the sample size. Using the expected HBsAg prevalence (P), D eff , and the maximum permissible error (d) for the different age groups in the study (P = 0.006, D eff = 1.5, and d = 0.0025 for age 1-4 years; P = 0.01, D eff = 2.0, and d = 0.005 for age 5-9 years; P = 0.015, D eff = 2.8, and d = 0.075 for age 10-14 years), the desired sample size was 11 419 and included 5480 children aged <5 years, 3043 children aged 5-9 years, and 2896 children aged 10-14 years. At least 92 children aged <5 years (5480/60), 51 children aged 5-9 years (3043/60), and 49 children aged 10-14 years (2896/60) at each sample site were enrolled. If the target population size at one sample site could not meet the average number needed for statistical significance, the remaining target population would be collected from the nearest village/community.
Investigation
A house-to-house investigation was completed by trained staff based on the sample list. An urban area was defined as a region, such as a county/city, that was the capital in the prefecture; rural areas were those counties that were not the capital of the prefecture. Through face-to-face interviews, the family was asked questions about their child's sex, date of birth, place of birth, immunization history, and whether they had one or more family members with hepatitis B confirmed by a hospital. Immunization status (vaccinated or not vaccinated) was recorded from the child's immunization certificate kept by the parents, or by a review of the child's immunization card kept at the township hospital immunization clinic; if neither was available, the village/ community doctor's registry was reviewed. If none of these sources was available, the vaccination status was recorded as unvaccinated.
Specimen collection
Blood samples were collected from each study participant, 3 ml for children >2 years of age and 2 ml for children aged 2 years; on the same day, the serum was separated in county laboratories and stored at À20 8C. The serum samples were then transported and stored at À20 8C at city laboratories within 1 week and submitted to HNCDC. 
Laboratory testing
All serum specimens were tested at HNCDC. A detailed laboratory testing protocol was established before testing, including the retesting of specimens with inconsistent results. All of the samples were screened for HBsAg and total hepatitis B core antibody (anti-HBc) using commercially-available enzymelinked immunosorbent assays (ELISA; Shanghai Kehua Bioengineering Co., Ltd, Shanghai, China). The tests were carried out and interpreted in accordance with the manufacturer's instructions.
Statistical analysis
All data were entered into an Epi Data (v. 3.02) software database twice and checked for consistency with the original records. After verifying accuracy, the data were analyzed at HNCDC using SPSS 17.0 software for Windows (SPSS Inc., Chicago, IL, USA). Proportions and ratios were used to describe the socio-demographic characteristics of the participants and their infection status regarding HBsAg positivity. The HBsAg and anti-HBc prevalences were standardized according to the 2010 Henan population structure. The Chi-square test was used to determine whether associations were statistically significant, and the level of statistical significance was set at p < 0.05. Multivariable logistic regression was used to identify factors affecting the prevalence of HBsAg in children aged 1-14 years; the dependent variable was the prevalence of HBsAg. The independent variables assessed in this study were having a family member with hepatitis B, traumatic behaviors (including pedicure, ear-piercing, tattoo), a history of surgery, a history of dental surgery, ethnicity (ethnic Han vs. other), immunization history, location of the community (urban vs. rural), place of birth (born in a hospital of a higher class than upper third-class (mainly city hospitals) vs. born in a hospital with a lower socioeconomic status (smaller township hospitals or at home)), and age. Odds ratios (ORs) and their 95% confidence intervals (CI) were also calculated.
Ethical issues
The survey protocol conformed to the ethics guidelines of the 1975 Declaration of Helsinki and was approved by the Henan CDC Medical Ethics Committee; all study work was performed in accordance with national ethics regulations. Study participants or their guardian were informed of the study purpose and of their right to keep information confidential. All of the survey results were shared with the families.
Results
The survey investigated 13 510 subjects in total. Blood samples were collected from 13 472 (99.7%) subjects, 13 443 (99.5%) of whom also provided questionnaire information. The 29 (0.2%) subjects who did not provide questionnaire information were excluded from the study. Among the houses visited, 94.5% of the occupants participated in the survey. Among these subjects, 13 207 (98.2%) were eligible for data analysis; 51 people were excluded because the questionnaire contained incomplete information, 20 were outside the study age range, and 165 were excluded because their serum samples were insufficient or displayed severe hemolysis.
Characteristics of the study population
The characteristics of the study population are shown in Table 1 . The male to female ratio was 1.16:1.
Results of HBV testing, distribution of HBV serological markers, and immunization status
Among the children in the eligible study population, 98 were positive for HBsAg (0.7%, 95% CI 0.6-0.8%) and 370 were positive for anti-HBc (2.8%, 95% CI 2.5-3.0%). The standardized prevalences adjusted to represent the Henan population age 1-14 years were 0.8% for HBsAg and 2.6% for anti-HBc. The prevalence of HBsAg varied by age group, increasing steadily from 0.5% (95% CI 0.3-0.7%) among children aged 1-4 years to 1.2% (95% CI 0.8-1.6%) among children aged 10-14 years ( Table 1) . Differences in prevalence were highly significant for the three 5-year age groups, but there was no difference between the 1-4 and 5-9 years age groups (p = 0.10). The association between the increased prevalence of anti-HBc positivity and the increase in age was similar to the trend observed for HBsAg positivity.
HBsAg prevalence was higher for females (0.8%, 95% CI 0.6-1.0%) than males (0.7%, 95% CI 0.5-0.9%) ( Table 1 ), but the difference was not significant (p = 0.44). The HBsAg prevalence among persons living in urban areas (0.4%, 95% CI 0.2-0.6%) was lower than among persons living in rural areas (1.0%, 95% CI 0.8-1.2%, p < 0.01). The prevalence of anti-HBc showed the same trend. Among the 98 HBsAg-positive persons, 96 (98.0%, 95% CI 95.6-100%) were anti-HBc-positive and two (2.0%, 95%CI, 0-4.8%) were anti-HBc-negative. Table 2 shows that the vaccination rate declined with increasing age. The vaccine coverage was significantly lower in the older age groups. The average vaccination rate was 96.3% (95% CI 96.0-96.6%).
Multivariable analysis of HBsAg status for children
Single-factor analysis was carried out for nine possible risk factors, including having one or more family members with hepatitis B, traumatic behavior, history of surgery, and history of dental surgery (Table 3) . Six risk factors were related to HBV infection (Table 3) . Further analysis by multivariate analysis showed that five of the risk factors listed in Table 3 were significantly related to HBV infection. The results of the multivariate analysis showed that if a child had an HBsAg-positive family member (OR 4.26), was unvaccinated (OR 2.06), and living in a rural area (OR 2.01), that child had a higher likelihood of HBsAg positivity than a child who did not have a family member with hepatitis B, who had been vaccinated, and who lived in an urban area (p < 0.05; Table 3 ). Children born in more sophisticated hospitals had the benefit of a reduced prevalence of HBsAg, while those born in smaller township hospitals or at home had a successively higher likelihood of HBsAg positivity (OR 1.61). Children aged 10-14 years had a higher prevalence of HBsAg positivity than children aged 1-9 years (OR 2.07; p < 0.01; Table 3 ).
Discussion
HBV infection and its sequelae have been recognized globally as serious problems. Worldwide, over 350 million individuals were reported to be chronically infected with HBV in 2006. 5 The
Western Pacific region is disproportionately affected by HBV, with over half of all deaths caused by this infection occurring in this region, despite having only around 28% of the global population. As estimated in 2002, of the 278 000 HBV-related deaths in the region each year, over 90% are due to chronic infections acquired decades earlier at birth or during early childhood. 6, 7 Thus far, three national HBV serological surveys have been conducted in China: one in 1979, the second in 1992, and the third in 2006. 4, 8 According to the 1992 national survey, the average rate of HBsAg positivity in the Chinese population was about 10%. Furthermore, this prevalence reached 9.67% in children under 5 years of age. In China, one survey showed that for children born during the period 1992-2001, the rates of three-dose and timely birth dose coverage with hepatitis B vaccine were 50.6% and 35.1%, respectively. For children born during 2002-2005, the rates of threedose and timely birth dose coverage with hepatitis B vaccine had increased to 89.4% and 73.4%, respectively, and these reached 93.4% and 82.6%, respectively, for children born in 2005. 9 The national HBV serological survey conducted in 2006 showed that children under 5 years of age had an infection rate of 1.0%, a decline of 90% compared to the infection rate in 1992. This decline is most likely attributable to the increase in immunization coverage ratios after 2002. Even within the same country, the modes of transmission of HBV vary between different regional, sex, and age groups. 1, 2, 10, 11 Additionally, because there are different levels of economic development in east, south, north, west, and central China, the effects of the implementation of immunization programs among the different provinces may not be consistent. This may lead to variations in the hepatitis B vaccine immunization rates in different target populations in different provinces. The present data showed that the HBsAg prevalence in children aged 1-4 years was 0.5%. This value is markedly lower than that recorded in the national HBV sero-epidemiological surveys conducted in 1992 and 2006. It is also lower than that reported for other regions of China and other counties. One survey reported in 2009 showed that the HBsAg prevalence rate in children aged 0-5 years was 0.96% in Zhejiang Province, China in 2007. 12 In 2012 and 2014, other surveys in Guangdong and Ganshu showed the HBsAg prevalence rate to be 1.99% and 1.3%, respectively, in the same age group in 2010. 13, 14 As reported in 2015, the HBsAg prevalence in 2012 was 2.3% in children aged 4-6 years in Papua New Guinea, where the hepatitis B vaccine was introduced for all infants starting in 1989, with the inclusion of a birth dose in 1992, but with low vaccine coverage (60-70% HepB3, 20-30% timely birth dose). 15 In 2014, Laos, where a phased HBV vaccine was introduced into the national immunization schedule from 2001, reported that the HBsAg prevalence was 4.6% in pre-school children in 2011. 16 In 2015, Nigeria, where the vaccination programs have not received adequate attention or funding by the government until now, reported that the prevalence of HBsAg in that country was 11.5% in children. 22 Obviously, the data listed above show that the earlier the immunization program was carried out in an area, the lower the HBsAg prevalence that was achieved in that area. More encouragingly, the prevalence of HBsAg among children aged 5-9 and 10-14 years in Henan Province has also decreased dramatically compared to the same age groups in China in 1992 and in 2006. In these cohorts, an estimated 2-3 million HBV carriers and 0.35-0.53 million future HBV-related deaths have been prevented. 7 There were significant differences in the HBsAg-positive rate between children who lived in urban and rural areas of Henan Province. The HBsAg-positive rate in the rural population under 15 years of age was higher than that in the urban population. Other studies in China have also indicated that the rural areas often have the highest HBsAg prevalence. 1, 3, 8, 9 Previous studies have reported that immunization coverage has often remained low in rural areas of China and that children born in rural areas are more likely not to receive a timely birth dose or full immunization. 13 In addition, women of childbearing age in rural areas are more likely to be HBsAg-and hepatitis B e antigen (HBeAg)-positive than women in urban areas. This may increase the rate of transmission of HBV infection from mother to child in rural areas. 23 Previous studies in China have reported that males often have higher HBV infection rates than females, and the difference has been reported as significant. [24] [25] [26] The significantly different rates of infection between males and females in China are often related to the entire population. The reasons for male adults having a higher HBV prevalence may be due to societal differences, such as more unsafe habits related to HBV infection for men, for example shaving in the barber shop. 14, 24, 26 The present results and the data of Shen et al. show that the difference in HBV prevalence between male and female children was not significant, especially among those covered by the universal vaccination program. 27 The slight difference between male and female children in this study may be due to random errors during the selection of samples and serological detection. The multivariate analysis provided useful insights into the risk factors for HBsAg positivity among children. The main risk factors for HBsAg positivity, in addition to a lack of vaccination, included birthplace (a predictor of health care and immunization access), age, place of residence, and whether the child had a family member with hepatitis B. Infants born in higher-level hospitals are much more likely to receive a birth dose of HepB (hepatitis B vaccine) than those born in lower-level hospitals or at home. 10, 28 In addition, in larger hospitals, mothers may be screened for HBsAg, and the infants of those mothers found to be positive may also be given HBIG (hepatitis B hyper-immune globulin). The hepatitis B vaccine has been offered free of charge to the general population in Henan since 2002, a period of exactly 10 years. Not surprisingly, the survey results showed that children aged 0 to 10 years had a low risk related to HBV infection compared to children aged 11-14 years. These data indicate that the free vaccine policy may have significantly enhanced the vaccination rate of newborns in Henan.
One study limitation is that study participation was limited to persons who had been resident in the surveillance points for 6 months or more; those children who had only been in the region for a short time were excluded. This would include children who had followed their migrant parents for a short work or study period and unregistered children born outside of family planning. As the majority of these children come from poorer, rural areas, they may have had a relatively high prevalence of HBsAg and lower likelihood of hepatitis B vaccination. Therefore, the data may underestimate the overall HBsAg prevalence. In addition, 452 subjects had to be disqualified from the sample list for health reasons (cerebral palsy, immunodeficiency, blood syncope, and hemodialysis patients) and 2.2% of the people who had originally agreed to participate in the survey did not attend the scheduled interviews. Exact vaccination doses/dates were not surveyed. Thus, some of the subjects in this study who had been vaccinated may have received an incomplete vaccination. In other words, they may have received one or two doses or their first vaccination was delayed. Since the first vaccination dose is very important for stopping HBV infection in children, these children may have been infected with HBV. In this study, these factors may increase the rate of HBV infection in the vaccinated population.
In conclusion, after two decades of vaccination, the HBsAg prevalence rate in persons under 15 years of age has dropped in Henan Province compared to the average HBsAg-positive ratio of China in 1992, meeting the goal set by the Chinese government (an HBsAg prevalence rate of less than 1% in children under 5 years old by 2010) and the World Health Organization (an HBsAg prevalence rate of less than 1% in children less than 5 years old in the AsiaPacific region by 2017). It was not possible to calculate the accurate decline ratio of HBsAg in persons under 15 years of age in Henan, China from 1992 to 2012 because these historical data were absent. As the first large sample size epidemiological serosurvey of HBV in persons under 15 years old in Henan, this study provides a baseline for other studies. These data suggest that free immunization programs for infants should continue to be made available and that each newborn should be immunized shortly after birth. In addition, in order to reduce the prevalence of HBsAg in the whole population, it is necessary to improve the care and treatment of chronic patients and to find and treat acute infectious patients as soon as possible. Finally, it is necessary to greatly improve the health education in rural areas to control HBV infection.
